Biomaterial development for cardiopulmonary bypass

Gourlay, T.
September 2001
Perfusion;Sep2001, Vol. 16 Issue 5, p381
Academic Journal
Cardiopulmonary bypass (CPB) is dependent on materials foreign to the patient for its successful application. When blood comes into contact with these so-called biomaterials, an inappropriate inflammatory response, which can be life-threatening in some patients, may develop. The reason for this inappropriate activation of host defence mechanisms is not entirely clear, however a number of strategies have evolved over the years to minimize this unwanted sequelae of CPB. These strategies include surface coating of the materials of the circuit, using new materials thought to improve biocompatibility, and using a number of pharmacological interventions designed to suppress the inflammatory response. Recently, there has been some evidence which indicates that the plasticizer employed in the polyvinyl chloride (PVC) tubing of the CPB circuit may play a part in the development of the inflammatory response. The work described in this paper tends to support this thesis. These studies showed that by washing the plasticizer from the surface of the PVC tubing, the biocompatibility, as reflected in the upregulation of CD11b on the surface of neutrophils, was enhanced. Furthermore, the use of non-plasticized substitutes for PVC had a similar effect. The benefit from removing the plasticizer was similar to that gained from surface coating with heparin, one of the conventional approaches to reducing the inflammatory response to CPB.


Related Articles

  • The inflammatory response to cardiopulmonary bypass: a therapeutic overview. Rubens, F.D.; Mesana, T. // Perfusion;Jan2004 Supplement 1, Vol. 19, p5 

    The demographic of cardiac surgery patients continues to evolve to include older, sicker candidates, all the while maintaining an expectation of excellent outcomes. These latter results can only be achieved by the parallel advancement and re-examination of the technology of cardiopulmonary...

  • Biomaterials in cardiopulmonary bypass. Courtney, J.M.; Zhao, X.; Qian, H. // Perfusion;1999, Vol. 14 Issue 4, p263 

    Discusses the clinical use of biomedical materials in cardiopulmonary bypass procedure. Blood response to biomaterials; Information on biomaterials; Process of polymer synthesis and modification.

  • Miniaturized biocompatible cardiopulmonary bypass for the Fontan procedure. Itatani, Keiichi; Miyaji, Kagami; Miyamoto, Takashi; Inoue, Nobuyuki; Tomoyasu, Takahiro; Kohira, Satoshi; Sato, Hajime; Ohara, Kuniyoshi // Surgery Today;Nov2010, Vol. 40 Issue 11, p1040 

    Purpose: Postoperative inflammatory response and perioperative systemic edema are the risks of failed Fontan circulation. We evaluated the efficiency of the miniaturized, poly-2-methoxyethylacrylate (PMEA)-coated cardiopulmonary bypass (CPB) circuit, which we devised in 2003, in the Fontan...

  • Does cardiopulmonary bypass still represent a good investment? The biomaterials perspective. Gourlay, T.; Connolly, P. // Perfusion;Jul2003, Vol. 18 Issue 4, p151 

    Cardiopulmonary (CPB) bypass is 50 years old this year, and has undergone considerable change in that time, particularly with regard to developing technology. However, in recent years the routine application of CPB, as the treatment of choice for patients undergoing reparative heart surgery, has...

  • Leukodepletion and aprotinin improve clinical outcome after extracorporeal circulation. Gott, J. // Perfusion;Mar2001 Supplement 1, Vol. 16, p5 

    Most cardiac operations involve the use of extracorporeal circulation with its attendant systemic inflammatory response syndrome. Many anti-inflammatory strategies hold promise for reducing the associated morbidity of cardiopulmonary bypass. The application of pharmacological and mechanical...

  • Strategic Leukofiltration in Cardiac Surgery. Gunaydin, S.; McCusker, K.; Vijay, V. // Current Medicinal Chemistry - Cardiovascular & Hematological Age;Oct2005, Vol. 3 Issue 4, p323 

    Systemic inflammatory response syndrome (SIRS) with activation of molecular cascades, cell activation, accumulation of interstitial fluid, organ dysfunction and, occasionally, organ failure is still a commonly recognized consequence of cardiac surgery. SIRS leads to costly complications and...

  • Insulin binding to the cardiopulmonary bypass biomaterials. Urban, Kristyn; Redford, Daniel; Larson, Douglas F. // Perfusion;May2007, Vol. 22 Issue 3, p207 

    Hyperglycemia associated with cardiopulmonary bypass (CPB) is an independent predictor of morbidity and mortality. One suggested cause of hyperglycemia during CPB is a decline of serum insulin concentrations. Since plasma C-proteins are not reduced during CPB - suggesting that pancreatic insulin...

  • The impact of different biocompatible coated cardiopulmonary bypass circuits on inflammatory response and oxidative stress. Sohn, N.; Marcoux, J.; Mycyk, T.; Krahn, J.; Meng, Q. H. // Perfusion;Jul2009, Vol. 24 Issue 4, p231 

    This study was to compare the impact of different biocompatible coated circuits on inflammatory response and oxidative stress induced during cardiopulmonary bypass (CPB). Seventy-eight patients undergoing elective coronary artery bypass grafting (CABG) with CPB were randomly assigned to five...

  • Antioxidant defence during cardiopulmonary bypass surgery Luyten, Chris R.; van Overveld, Frans J.; De Backer, Lieve A.; Sadowska, Anna M.; Rodrigus, Inez E.; De Hert, Stefan G.; De Backer, Wilfried A. // European Journal of Cardio-Thoracic Surgery;Apr2005, Vol. 27 Issue 4, p611 

    Abstract: Objective: Cardiac surgery may lead to severe oxidative stress due to formation of oxidation products generated during ischemia and reperfusion. We investigated to which extent oxidative stress influences a number of endogenous antioxidants and markers of cellular activation. Methods:...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics